A15 Respiratory tuberculosis

Name of the Condition

• Respiratory tuberculosis (ICD-10: A15)

Summary

Respiratory tuberculosis is a contagious bacterial infection primarily affecting the lungs and other parts of the respiratory system. It is caused by Mycobacterium tuberculosis and spreads through airborne droplets. TB is a significant public health concern, particularly in regions with limited healthcare access or high poverty rates.

Causes

Respiratory tuberculosis is caused by the bacterium Mycobacterium tuberculosis. Infection occurs when a person inhales respiratory droplets containing the bacteria, typically from an individual with active TB. The bacteria can settle in the lungs and multiply, leading to infection.

Risk Factors

• Prolonged exposure to someone with active TB.
• Living in or traveling to areas with high TB prevalence.
• Compromised immune system (e.g., HIV/AIDS, diabetes).
• Substance abuse, including alcohol and tobacco.
• Malnutrition or poor living conditions.

Symptoms

• Persistent cough (lasting three weeks or more).
• Hemoptysis (coughing up blood).
• Fever, chills, and night sweats.
• Unintended weight loss.
• Chest pain or discomfort.
• Fatigue and weakness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A chest X-ray may show characteristic lung changes, while sputum tests (microscopy, culture, or nucleic acid amplification) confirm the presence of M. tuberculosis. Tuberculin skin tests (TST) or interferon-gamma release assays (IGRAs) assess exposure or infection.

Treatment Options

• Antibiotics: A multi-drug regimen (e.g., isoniazid, rifampin) for 6–9 months is standard.
• Directly Observed Therapy (DOT): Ensures adherence to treatment.
• Hospitalization: May be required for severe cases or drug-resistant TB.
• Supportive care: Managing symptoms like fever or pain.

Prognosis and Follow-Up

With proper treatment, most patients recover fully. However, drug-resistant strains or delayed diagnosis can worsen outcomes. Follow-up includes monitoring for treatment response, side effects, and potential relapse. Regular sputum tests and clinical assessments are typical during therapy.

Complications

• Lung damage or respiratory failure.
• Spread to other organs (e.g., brain, kidneys).
• Drug-resistant TB.
• Recurrence after treatment completion.

Lifestyle & Prevention

• Avoid close contact with active TB cases.
• Ensure good ventilation in living spaces.
• Complete TB screening and treatment if exposed.
• Maintain a healthy immune system through nutrition and exercise.
• Follow public health guidelines in high-prevalence areas.

When to Seek Professional Help

Seek care if you have a persistent cough, unexplained weight loss, or fever lasting more than two weeks. Immediate attention is needed for hemoptysis, severe chest pain, or signs of respiratory distress.

Tips for Medical Coders

Use code A15 for respiratory tuberculosis when the site is unspecified or involves multiple respiratory sites (e.g., lung, bronchus). Document the clinical findings, diagnostic tests, and treatment plan to support coding accuracy. Ensure alignment with ICD-10-CM guidelines for respiratory TB classification.